Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Randomized, Blank-controlled, Open Label Study of the Safety and Efficacy of Propranolol in Reducing Stroke Associated Pneumonia and Urinary Tract Infection

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT05375240
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:38:39.298321+00:00
Published At
2022-05-16T00:00:00+00:00
Record Updated At
2022-05-16
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Stroke", "Cerebrovascular Disorders", "Ischemic Stroke", "Brain Diseases", "Central Nervous System Diseases", "Nervous System Diseases", "Cardiovascular Diseases", "Propranolol", "Beta Blocker", "Molecular Mechanisms of Pharmacological Action", "Immunologic Factors", "Physiological Effects of Drugs"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2022-05-16"
protocolSection.identificationModule.nctId
"NCT05375240"
protocolSection.identificationModule.officialTitle
"A Randomized, Blank-controlled, Open Label Study of the Safety and Efficacy of Propranolol in Reducing Stroke Associated Pneumonia and Urinary Tract Infection"
protocolSection.statusModule.overallStatus
"UNKNOWN"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Stroke (protocolSection.conditionsModule.conditions)
  • Cerebrovascular Disorders (protocolSection.conditionsModule.conditions)
  • Ischemic Stroke (protocolSection.conditionsModule.conditions)
  • Brain Diseases (protocolSection.conditionsModule.conditions)
  • Central Nervous System Diseases (protocolSection.conditionsModule.conditions)
  • Nervous System Diseases (protocolSection.conditionsModule.conditions)
  • Cardiovascular Diseases (protocolSection.conditionsModule.conditions)
  • Propranolol (protocolSection.conditionsModule.conditions)
  • Beta Blocker (protocolSection.conditionsModule.conditions)
  • Molecular Mechanisms of Pharmacological Action (protocolSection.conditionsModule.conditions)
  • Immunologic Factors (protocolSection.conditionsModule.conditions)
  • Physiological Effects of Drugs (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.